Laboratory Of Stock Performance
| LH Stock | USD 250.47 7.43 3.06% |
Laboratory has a performance score of 10 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 1.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Laboratory will likely underperform. Laboratory right now secures a risk of 1.41%. Please verify Laboratory of potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to decide if Laboratory of will be following its current price movements.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Laboratory of are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical indicators, Laboratory may actually be approaching a critical reversion point that can send shares even higher in August 2025. ...more
Actual Historical Performance (%)
One Day Return (0.28) | Five Day Return (0.88) | Year To Date Return 6.51 | Ten Year Return 133.47 | All Time Return 1.1 K |
Forward Dividend Yield 0.011 | Payout Ratio | Last Split Factor 1164:1000 | Forward Dividend Rate 2.88 | Dividend Date 2025-09-11 |
1 | Disposition of 323 shares by Van Der Vaart Sandra D of Laboratory subject to Rule 16b-3 | 05/09/2025 |
| Laboratory dividend paid on 11th of June 2025 | 06/11/2025 |
2 | Mill Capital Management LLC Boosts Stock Position in Labcorp Holdings Inc. | 06/25/2025 |
3 | Disposition of 500 shares by Kerrii Anderson of Laboratory at 265.0 subject to Rule 16b-3 | 07/01/2025 |
4 | Labcorp Holdings Inc. Shares Sold by Financial Counselors Inc. | 07/08/2025 |
5 | Labcorp Holdings declares 0.72 dividend | 07/10/2025 |
6 | Chalk River Laboratories Becomes First GLP-Certified Laboratory in Canada to Offer Pre-Clinical Radiopharmaceutical Studies | 07/15/2025 |
7 | Laboratory Freezers Market Set to Reach USD 7.48 Billion by 2032, Fueled by Rising Pharmaceutical RD and Biotech Innovation - SNS Insider | 07/16/2025 |
8 | NASAs Jet Propulsion Laboratory Reportedly Holding Going Out of Business Sale for Satellites | 07/17/2025 |
9 | Labcorp Holdings UBS Maintains Buy Rating, Lowers Price Target LH Stock News | 07/18/2025 |
| Begin Period Cash Flow | 536.8 M | |
| Total Cashflows From Investing Activities | -1.4 B |
Laboratory | Build AI portfolio with Laboratory Stock |
Laboratory Relative Risk vs. Return Landscape
If you would invest 22,349 in Laboratory of on April 23, 2025 and sell it today you would earn a total of 2,698 from holding Laboratory of or generate 12.07% return on investment over 90 days. Laboratory of is generating 0.1937% of daily returns and assumes 1.4053% volatility on return distribution over the 90 days horizon. Put differently, 12% of stocks are less risky than Laboratory on the basis of their historical return distribution, and some 97% of all equities are expected to be superior in generating returns on investments over the next 90 days. Expected Return |
| Risk |
Laboratory Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Laboratory's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Laboratory of, and traders can use it to determine the average amount a Laboratory's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1378
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.41 actual daily | 12 88% of assets are more volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 10 90% of assets perform better |
Based on monthly moving average Laboratory is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Laboratory by adding it to a well-diversified portfolio.
Laboratory Fundamentals Growth
Laboratory Stock prices reflect investors' perceptions of the future prospects and financial health of Laboratory, and Laboratory fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Laboratory Stock performance.
| Return On Equity | 0.0898 | ||||
| Return On Asset | 0.0418 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 26.55 B | ||||
| Shares Outstanding | 83.7 M | ||||
| Price To Earning | 12.69 X | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 1.55 X | ||||
| Revenue | 13.01 B | ||||
| Gross Profit | 3.68 B | ||||
| EBITDA | 1.81 B | ||||
| Net Income | 746 M | ||||
| Cash And Equivalents | 1.52 B | ||||
| Cash Per Share | 4.63 X | ||||
| Total Debt | 7.27 B | ||||
| Debt To Equity | 0.63 % | ||||
| Current Ratio | 1.73 X | ||||
| Book Value Per Share | 99.13 X | ||||
| Cash Flow From Operations | 1.59 B | ||||
| Earnings Per Share | 8.68 X | ||||
| Market Capitalization | 20.4 B | ||||
| Total Asset | 18.38 B | ||||
| Retained Earnings | 8.3 B | ||||
| Working Capital | 1.48 B | ||||
| Current Asset | 585.1 M | ||||
| Current Liabilities | 226.4 M | ||||
About Laboratory Performance
By evaluating Laboratory's fundamental ratios, stakeholders can gain valuable insights into Laboratory's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Laboratory has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Laboratory has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 18.94 | 10.58 | |
| Return On Tangible Assets | 0.09 | 0.14 | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Assets | 0.04 | 0.04 | |
| Return On Equity | 0.09 | 0.18 |
Things to note about Laboratory performance evaluation
Checking the ongoing alerts about Laboratory for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Laboratory help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Laboratory has a strong financial position based on the latest SEC filings | |
| Over 96.0% of the company shares are owned by institutional investors | |
| On 11th of June 2025 Laboratory paid $ 0.72 per share dividend to its current shareholders | |
| Latest headline from gurufocus.com: Labcorp Holdings UBS Maintains Buy Rating, Lowers Price Target LH Stock News |
- Analyzing Laboratory's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Laboratory's stock is overvalued or undervalued compared to its peers.
- Examining Laboratory's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Laboratory's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Laboratory's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Laboratory's stock. These opinions can provide insight into Laboratory's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Laboratory Stock analysis
When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |